BCL2L13 and acute myeloid leukemia: BCL-RAMBO is expressed in various cancers, including childhood acute lymphoblastic leukemia (ALL), gastric cancer, glioblastoma, and acute myeloblastic leukemia (Holleman et al., 2006; Tahir et al., 2010; Yang et al., 2010; Wang et al., 2013; Jensen et al., 2014; Handschuh et al., 2021).